Which are the most promising new medications in phase 3 clinical trials for the treatment of painful large joint arthritis?
What is the role of transdermal fentanyl patches in management of cancer pain?
Towards a better understanding of interstitial lung diseases associated with autoimmune rheumatic diseases - Optimising the monitoring and treatment of SSc-ILD
Highlights of the 2019 EASD Congress
DAPA HF : The Dapagliflozin And Prevention Of Adverse‑ outcomes In Heart Failure Trial
Early intervention with oral semaglutide and long term safety
VERIFY and CONCLUDE study
Clinical properties and differences between GLP-1 agonists
Why We Should Still Care about Glycemic Lowering Strategies for Type 2 Diabetes
Diabetic retinopathy: Is the eye a mirror of the brain?
Cardiovascular risk factors
Leading role of hypertension in CV risk scene
Controversial issues in guidelines
Cardiovascular mode of action of GLP-1 receptor agonists
Exploring the effects of SGLT2 inhibition in ongoing clinical trials
Medical Devices in Diabetes
Will SGLT2-inhibitors change the landscape?
Innate immunity in pancreatic islet inflammation
The artificial beta cell. When will the dream become reality?
Observational study of insulin pump treatment
The evidence for metformin is unclear?
The ORIGIN Study And Legacy Effects
EMPA-REG OUTCOME - a long-term, outcom study of empagliflozin in pateints with T2D at high CV risk
Principal investigator presenting the results of EMPA-REG OUTCOME trial
Mathematic modelling of fibrinolysis
Pre and perioperative factors modulate fibrinolysis in arthroplasty patients
Cellular and mechanical modulators of fibrin structure
Platelets, NETs and Immunity
Mechanisms by which DNA, histones and NETs stabilise clots
Free fatty acids modulate thrombin activity ov fibrinogen and destabilise fibrin clots
Genetics of thrombosis
Blood Test Shows Promise for Early Detection of Acute Heart Transplant Rejection
Early differences in cytokine production distinguish severity of COVID-19: Study
Statins May Protect Hearts From Damage Caused by Breast Cancer Chemotherapy
Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction
EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU
Study finds blood vessel damage and inflammation in brains of patients with COVID-19, but no SARS-CoV-2 infection
Risk factor study offers more comprehensive look at COVID-19 prognosis in nursing home residents
High prevalence of occult thrombosis in mild/moderate COVID-19
Pregnant women unlikely to pass SARS-CoV-2 infection to newborns: Study
Italian population study finds low rate of SARS-CoV-2 infection in patients undergoing cancer treatment
FDA’s vaccine committee votes in favour of issuing EUA for Moderna's COVID-19 vaccine
Study suggests newly diagnosed cancer patients more at risk for COVID-19
Scoring System Improves Screening for Dual Heart Disease
BNT162b2 vaccine confers 95% protection against COVID-19: Study
Study suggests proton pump inhibitor or famotidine use associated with severe COVID-19
Interim WHO trial results show repurposed antiviral drugs for COVID-19 have “little or no effect” on inpatients